US 12,029,812 B2
Compositions and methods for treating an infection
Jay Richard Ray, Conroe, TX (US)
Assigned to CMPD Licensing, LLC, Conroe, TX (US)
Filed by CMPD LICENSING, LLC, Conroe, TX (US)
Filed on Sep. 19, 2022, as Appl. No. 17/947,789.
Application 17/947,789 is a continuation of application No. 16/702,032, filed on Dec. 3, 2019, granted, now 11,446,236.
Application 16/702,032 is a continuation in part of application No. 15/881,009, filed on Jan. 26, 2018, granted, now 10,898,491, issued on Jan. 26, 2021.
Application 16/702,032 is a continuation in part of application No. 16/270,335, filed on Feb. 7, 2019, abandoned.
Application 15/881,009 is a continuation in part of application No. 15/625,989, filed on Jun. 16, 2017, abandoned.
Application 15/625,989 is a continuation in part of application No. 14/975,172, filed on Dec. 18, 2015, granted, now 9,707,229, issued on Jul. 18, 2017.
Application 15/625,989 is a continuation in part of application No. 15/440,800, filed on Feb. 23, 2017, abandoned.
Application 16/270,335 is a continuation in part of application No. 15/976,579, filed on May 10, 2018, granted, now 11,278,590, issued on Mar. 22, 2022.
Application 15/976,579 is a continuation in part of application No. 14/990,168, filed on Jan. 7, 2016, granted, now 10,898,455, issued on Jan. 26, 2021.
Application 15/976,579 is a continuation in part of application No. 15/597,936, filed on May 17, 2017, granted, now 10,105,342, issued on Oct. 23, 2018.
Application 15/976,579 is a continuation in part of application No. 15/668,184, filed on Aug. 3, 2017, abandoned.
Application 15/597,936 is a continuation in part of application No. 15/440,800, filed on Feb. 23, 2017, abandoned.
Application 15/597,936 is a continuation in part of application No. 14/975,172, filed on Dec. 18, 2015, granted, now 9,707,229, issued on Jul. 18, 2017.
Application 15/597,936 is a continuation in part of application No. 14/819,342, filed on Aug. 5, 2015, granted, now 10,973,804, issued on Apr. 13, 2021.
Claims priority of provisional application 62/370,571, filed on Aug. 3, 2016.
Claims priority of provisional application 62/298,994, filed on Feb. 23, 2016.
Claims priority of provisional application 62/298,991, filed on Feb. 23, 2016.
Prior Publication US 2023/0015656 A1, Jan. 19, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/14 (2006.01); A61K 31/4178 (2006.01)
CPC A61K 9/0014 (2013.01) [A61K 9/0073 (2013.01); A61K 9/06 (2013.01); A61K 9/14 (2013.01); A61K 31/4178 (2013.01)] 7 Claims
 
1. A topical composition for administration to skin or a vaginal or anal mucosal surface of a subject to treat a bacterial infection thereof, the topical composition comprising:
nitrofurantoin, carboxymethylcellulose sodium, anhydrous citric acid, glycerin, magnesium aluminum silicate, methylparaben, flavoring agents, propylparaben, purified water, saccharin sodium, sodium citrate, sorbitol, and a keratolytic agent selected form urea, salicylic acid, papain, or combinations thereof.